Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY: UNH )

567.56 +3.06 (+0.54%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
70 71 Next >
CVS Health's Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion. 
Via Benzinga
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
Healthcare is an excellent place to find some tried and true wealth compounders. 
Via The Motley Fool
34% of the Dow Jones Industrial Average's Weighting Is Determined by Just 5 Stocks
Five well-known Dow Jones components account for more than a third -- over 13,100 points -- of its value. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Insights Into UnitedHealth Group's Performance Versus Peers In Health Care Providers &amp; Services Sector
Via Benzinga
Blue-Chip Bonanza: 3 Rock-Solid Stocks to Grab in February 2024
PepsiCo (PEP), UnitedHealth Group (UNH), and Deere & Co. (DE) are the 3 best blue-chip stocks for investors to grab in February 2024. 
Via InvestorPlace
(UNH) - Analyzing UnitedHealth Group's Short Interest
Via Benzinga
Here's How Much $100 Invested In UnitedHealth Group 10 Years Ago Would Be Worth Today
Via Benzinga
Market Whales and Their Recent Bets on UNH Options
Via Benzinga
Looking At UnitedHealth Group's Recent Unusual Options Activity
Via Benzinga
UnitedHealthcare Launches Program to Address Type 2 Diabetes in Owensboro Community
From UnitedHealthcare
Via Business Wire
Healthcare And Life Science Funds And ETFs Performance 2023-2024
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?
UnitedHealth Group would need to more than double for it to reach a $1 trillion valuation. 
Via The Motley Fool
7 Mutual Funds That Will Outperform in Any Market
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
Via InvestorPlace
Blue-Chip Beauties: 3 Stable Stocks to Buy for Long-Term Growth
Three stable blue-chip stocks that boast strong financials, durable competitive advantages and histories of weathering volatility. 
Via InvestorPlace
World’s largest radiology AI marketplace CARPL raises $6m to accelerate the adoption of AI in clinical workflows
--News Direct-- 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Growth Stocks That Have Raised Their Dividends for the Past 14+ Years
Don't let these modest yields deceive you -- these are some promising dividend investments to load up on. 
Via The Motley Fool
3 Sectors to Avoid Even in a Booming Economy
Even with the economy performing very well, some sectors are on the wrong side of powerful, ongoing trends. Here are three sectors to avoid. 
Via InvestorPlace
Topics Economy
Exposures Economy
Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot
Healthcare stocks to buy are not talked about as much right now, but are great stocks investors should consider adding. 
Via InvestorPlace
3 Stocks That Top Funds Kicked to the Curb
Investors should avoid these stocks dropped by funds in the third quarter. Top funds usually sell stocks for good reasons. 
Via InvestorPlace
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance 
Via MarketBeat
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
Team up with the schoolyard bully so to speak with these compelling ideas for hedge fund favorite stocks to buy. 
Via InvestorPlace
Jim Cramer Won't Press 'Buy Button' On This Stock, Calls Out Insurers: 'They Have No Idea What's Going On'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended to buy Constellation Energy Corporation (NASDAQ: CEG). "All the kin of energy that I like under one roof," he added. 
Via Benzinga
Microsoft Hits an All-Time High, But It's Still Some Way From Becoming the Most Important Stock in the Dow Jones Industrial Average
Microsoft has to add nearly a trillion in value to become the most valuable stock in the Dow. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
NICHOLS KASTER AND CALIFORNIA CIVIL RIGHTS LAW GROUP FILE SEX AND SEXUAL ORIENTATION DISCRIMINATION CLASS ACTION AGAINST GEICO, UNITED HEALTHCARE SERVICES, AND UNITEDHEALTH GROUP
January 29, 2024 -- The complaint alleges that this policy was unfair and facially discriminated on the basis of sex and/or sexual orientation. 
Via 24-7 Press Release
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns? 
Via The Motley Fool
3 Blue-Chip Stocks to Buy and Hold Forever: January 2024
Investors playing the long game should allocate capital to these blue-chip stocks. Each of them can earn solid returns. 
Via InvestorPlace
5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen
With mega-cap stocks setting new highs, here are five new names that could take the Magnificent 7 to a Dynamic Dozen. 
Via InvestorPlace
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape. 
Via Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion. 
Via Benzinga
Humana Dives On Huge 2024 Earnings Warning
The health insurer says earnings will be barely half of estimates. 
Via Investor's Business Daily
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
70 71 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.